SAB Biotherapeutics, Inc. (NASDAQ:SABSW – Get Rating) saw a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 8,100 shares, a drop of 64.9% from the February 28th total of 23,100 shares. Based on an average trading volume of 5,400 shares, the days-to-cover ratio is […]